Fust Matthew K

Neumora Therapeutics, Inc. Common Stock · Director

Fust Matthew K is listed in public filings as director. This Fust Matthew K insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Neumora Therapeutics, Inc. Common Stock (NMRA), Ultragenyx Pharmaceutical Inc (RARE), Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX), and Atara Biotherapeutics, Inc. (ATRA). Investors use Fust Matthew K's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountCurrent Price
Neumora Therapeutics, Inc. Common StockNMRA$149k80k sharesGrant / ExerciseMay 27, 2026$148.8K80k shares$1.86--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Ultragenyx Pharmaceutical IncRARE$363k14.1k sharesGrant / ExerciseMay 14, 2026$362.7K14.1k shares$25.80--
Ultragenyx Pharmaceutical IncRARE--33.7k sharesGrant / ExerciseMay 14, 2026Disclosure amount unavailable7.8k shares----
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$1.0M22.8k sharesSellSep 26, 2025$716.0K16k shares$44.75--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$4.0k2.1k sharesGrant / ExerciseSep 26, 2025$19.1K10k shares$1.91--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$335k10.4k sharesGrant / ExerciseJun 11, 2025$334.6K10.4k shares$32.33--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX--28.8k sharesGrant / ExerciseJun 11, 2025Disclosure amount unavailable6.9k shares----
Atara Biotherapeutics, Inc.ATRA--18.2k sharesGrant / ExerciseJun 10, 2025Disclosure amount unavailable7.8k shares----
Neumora Therapeutics, Inc. Common StockNMRA$62k85.6k sharesGrant / ExerciseMay 28, 2025$61.6K85.6k shares$0.72--
Neumora Therapeutics, Inc. Common StockNMRA$58k80k sharesGrant / ExerciseMay 28, 2025$57.6K80k shares$0.72--
Neumora Therapeutics, Inc. Common StockNMRA$028.6k sharesOtherMay 28, 2025$48.3K28.6k shares$1.69--
Neumora Therapeutics, Inc. Common StockNMRA$21k28.6k sharesGrant / ExerciseMay 28, 2025$20.6K28.6k shares$0.72--
Neumora Therapeutics, Inc. Common StockNMRA$20k27.8k sharesGrant / ExerciseMay 28, 2025$20.0K27.8k shares$0.72--
Ultragenyx Pharmaceutical IncRARE$376k10.8k sharesGrant / ExerciseMay 15, 2025$375.8K10.8k shares$34.84--
Ultragenyx Pharmaceutical IncRARE--25.9k sharesGrant / ExerciseMay 15, 2025Disclosure amount unavailable5.7k shares----
Neumora Therapeutics, Inc. Common StockNMRA$027.8k sharesOtherFeb 13, 2025$472.6K27.8k shares$17.00--
Neumora Therapeutics, Inc. Common StockNMRA$028.6k sharesOtherFeb 13, 2025$284.3K28.6k shares$9.95--
Neumora Therapeutics, Inc. Common StockNMRA$085.6k sharesOtherFeb 13, 2025$214.8K85.6k shares$2.51--
Neumora Therapeutics, Inc. Common StockNMRA$145k85.6k sharesGrant / ExerciseFeb 13, 2025$144.6K85.6k shares$1.69--
Neumora Therapeutics, Inc. Common StockNMRA$48k28.6k sharesGrant / ExerciseFeb 13, 2025$48.3K28.6k shares$1.69--
Neumora Therapeutics, Inc. Common StockNMRA$47k27.8k sharesGrant / ExerciseFeb 13, 2025$47.0K27.8k shares$1.69--
Neumora Therapeutics, Inc. Common StockNMRA$342k20.1k sharesSellOct 18, 2024$239.3K14k shares$17.03--
Neumora Therapeutics, Inc. Common StockNMRA$06.2k sharesGrant / ExerciseOct 18, 2024$54.5K6.2k shares$8.79--
Neumora Therapeutics, Inc. Common StockNMRA$86k34.1k sharesGrant / ExerciseOct 18, 2024$19.8K7.8k shares$2.52--
Neumora Therapeutics, Inc. Common StockNMRA$342k20.1k sharesSellOct 17, 2024$131.6K7.7k shares$17.01--
Neumora Therapeutics, Inc. Common StockNMRA$03.8k sharesGrant / ExerciseOct 17, 2024$31.5K3.8k shares$8.32--
Neumora Therapeutics, Inc. Common StockNMRA$55k6.2k sharesGrant / ExerciseOct 17, 2024$15.8K1.8k shares$8.79--
Neumora Therapeutics, Inc. Common StockNMRA$70k27.8k sharesGrant / ExerciseOct 17, 2024$5.4K2.2k shares$2.52--
Ultragenyx Pharmaceutical IncRARE$370k9.9k sharesGrant / ExerciseJun 18, 2024$370.5K9.9k shares$37.42--
Ultragenyx Pharmaceutical IncRARE--20.2k sharesGrant / ExerciseJun 18, 2024Disclosure amount unavailable5.3k shares----
Fust Matthew K | TradingNote